Arqt Stock Analysis Arcutis Biotherapeutics Drops 1.95 To 23.63 Amid Biotech Volatility 20260403 GCBC Q2 2025 Earnings Solid EPS Performance Amid Steady Banking Operations NCR Atleos NATL Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower FCNCO Q1 2026 Earnings Preferred Dividend Coverage Strengthens with EPS Surprise FORTY Q1 2025 Earnings Reporting EPS of 123 Amid Stock Pullback DAKT Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Disappointing Start Veracyte VCYT Q1 2026 Earnings Stellar EPS Beat Highlights Operational Efficiency Broadcom Meta and Industry Giants Invest 125 Million in UCLA Semiconductor Research Hub xAI Faces Employee Payment Delays Over 420 Tax Return Incentive DAL Q1 2026 Earnings EPS Beats Estimates by 1067 as Travel Demand Remains Robust elf Beauty ELF Q1 2026 Earnings EPS Beats Estimates Amid Solid Execution Western Automakers Leverage Chinese Overcapacity to Export Affordable Vehicles to Home Markets Pearl Diver Credit Company Inc 800 Series A Preferred Stock Due 2029 PDPA Q4 2025 Earnings Preferred EPS Misses Estimates as Credit Market Headwinds Emerge Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline Aditxt Inc ADTX Q3 2025 Earnings Deepening Losses and No Revenue Weigh on Shares CareTrust REIT Inc CTRE Q1 2026 Earnings Slight EPS Miss Fails to Dampen Investor Sentiment TRVI Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Development Stage BWNB Q1 2026 Earnings Significant EPS Miss Triggers Negative Market Response KURA Q1 2026 Earnings WiderThanExpected Loss Amid Clinical Progress KRO Q1 2026 Earnings NarrowerthanExpected Loss Despite Market Challenges